Recent studies suggest that analyzing CSF CHI3L1 in conjunction with neurofilament light chain protein (NFL) could improve the differentiation of MS phenotypes [162], as NFL correlates with disease activity while CHI3L1 is associated with disease progression [170, 171]. This evidence concerns the gene NEFL and myeloid sarcoma.